December 17, 2024 04:24 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GRAP 4 restrictions reimposed in Delhi as air quality dips to 'severe' category | 39 ministers included in Devendra Fadnavis-led Maharashtra cabinet | People who raise questions on EVMs should show how they can be hacked: TMC trashes Congress claims | Bangladesh likely to hold national polls in late 2025 or early 2026, says Yunus in Victory Day speech | Constitution stood test of time: Nirmala Sitharaman in Rajya Sabha | PM Museum requests Rahul Gandhi to return Pandit Nehru's historical letters | Indian tabla maestro Zakir Hussain dies at 73 in San Francisco, confirms family | Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested
India
Photo Courtesy: PIB

Central Drugs Standard Control Organization hosts 7th India-Japan Medical Product Regulatory Symposium

| @indiablooms | Jul 12, 2024, at 06:23 am

The 7th India-Japan Medical Product Regulatory Symposium, organised by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare, Government of India, was successfully held at the FICCI Convention Hall on July 10.

The event was conducted in accordance with the Memorandum of Cooperation (MoC) between India and Japan, aimed at fostering collaboration in medical product regulations.

The symposium brought together approximately 200 delegates from the Ministry of Health & Family Welfare, India, and the Ministry of Health, Law and Welfare, Japan. Regulatory authorities from CDSCO, India, and PMDA, Japan, along with industry representatives from the Pharmaceutical Sector, Medical Devices Sector, and Biologicals-Biosimilar sector, actively participated in constructive discussions.

The MoC, originally signed in December 2015 between CDSCO and the Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceutical and Medical Devices Agency (PMDA) of Japan, underscores mutual cooperation in medical products regulations until December 2025.

These Regulatory Symposiums are held alternatively in India and Japan, serving as crucial platforms for exchanging insights and enhancing regulatory practices.

The symposium featured insightful presentations by Indian and Japanese Drug Regulatory Authorities, followed by in-depth discussions on emerging topics in Pharma, Medical Devices, and Regenerative Medicines.

These deliberations were pivotal in updating industry stakeholders on the latest regulatory initiatives in both countries.

The inaugural session of the symposium was graced by esteemed dignitaries including Shree. Rajiv Wadhawan, Joint Secretary, MoHFW, Dr. Rajeev Singh Raghuvanshi, DCGI, CDSCO, Yada Shinji, Executive Director, PMDA, Dr. Hirota Mitsue, Deputy Director, MHLW, and Ranga Chandrashekar, JDCI, CDSCO.

The event garnered participation from 80 drug regulators and 120 industry representatives from India and Japan, facilitating fruitful exchanges on regulatory updates and best practices.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu